Results 81 to 90 of about 726,866 (303)

The Age of Big Data [PDF]

, 2015
We are entering the 'Age of Big Data' – an extremely large amount of information is created every day, which is revolutionizing science and technology, governments, economy, and international development.
Cheng, CK
core  

SDN helps volume in Big Data [PDF]

, 2018
Both Big Data and SDN are described in detail in previous chapters. This chapter investigates how SDN architecture can leverage its unique features to mitigate the challenges of Big Data volume.
Taheri, Javid,, Alizadeh Noghani, Kyoomars,, Hernandez Benet, Cristian,   +2 more
core   +1 more source

Association Between Dinutuximab Beta Exposure and Post‐End‐of‐Treatment Survival in Neuroblastoma: A Weighted Patient‐Level Analysis of Three Clinical Studies

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Objectives The association between exposure to dinutuximab beta (DB) and event‐free survival (EFS) or overall survival (OS) of neuroblastoma patients was assessed using data collected during three clinical trials (five cohorts). Methods A systematic review (March 2026) was conducted to identify relevant studies (prospective; registered DB ...
Przemysław Holko, Holger N. Lode, Alberto Garaventa, Carla Manzitti, Roberto Luksch, Dominique Valteau‐Couanet, Marion Gambart, John Anderson, Juliet Gray, Adela Canete, Lucas Moreno, Aleksandra Wieczorek, Cormac Owens, Shifra Ash, Isaac Yaniv, Genevieve Laureys, Hans Loibner, Katarzyna Śladowska, Ruth Ladenstein, Paweł Kawalec   +19 more
wiley   +1 more source

What is Big Data [PDF]

, 2019
The article attempts to uncover the essence of the concept of Big Data based on the analysis of materials from various sources. Defining characteristics of Big Data are given, their classification is given, a brief description of the origin and ...
Reznichenko, V.A.
core  

BMT4me En Español: Multisite Feasibility and Usability Testing of a Spanish‐Language mHealth Adherence Support App for Spanish‐Speaking Caregivers of Children After Hematopoietic Stem Cell Transplantation and Cancer Treatment

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Medication nonadherence during the first 100 days after pediatric hematopoietic stem cell transplantation (HSCT) and during oncology treatment increases risk for complications. BMT4me is a caregiver‐facing mobile health (mHealth) application providing medication reminders, symptom tracking, and note‐taking features to support ...
Micah A. Skeens, Madeline R. Peek, Bianca Franklin, Emre Sezgin, Melissa Beauchemin   +4 more
wiley   +1 more source

Bridging Domains in Fingerprint Recognition With Quality-Normalized Fusion

IET Biometrics
Cross-domain fingerprint recognition remains difficult when latent impressions and smartphone finger photos are matched against contact-based sensor templates. We study this problem in the latent fingerprints in the wild (LFIW) database.
Xinwei Liu, Ning Fang, Peiyuan Zhang, Liangbin Zhang   +3 more
doaj   +1 more source

Big Data, Big Future

BioTechniques, 2020
With our increasing capabilities in research techniques and tools comes an inevitable increase in the amount of data and the complexity of datasets. But how do we cope with this plethora of data?
openaire   +2 more sources

Data by data, Big Data [PDF]

Croatian Medical Journal, 2019
Komentar na korištenje "big data" u medicinskom ...
openaire   +2 more sources

T2* Magnetic Resonance Imaging Uncovers Hemosiderin Burden in Pediatric Hemophilia: A Call for Sensitive Imaging Biomarkers

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Hemophilic arthropathy remains the leading morbidity in hemophilia despite modern prophylaxis, and early joint damage may be missed by routine exams. This study explored T2* MRI as a noninvasive biomarker of hemosiderin deposition in pediatric hemophilia.
Jessica Garcia, Tarique Hussain, Jeanne Dillenbeck, Matthew Hammer, Annette von Drygalski, Guy Young, Ayesha Zia   +6 more
wiley   +1 more source

Survival by Race and Ethnicity in Children and Adolescents/Young Adults With Relapsed/Refractory Hodgkin Lymphoma: A Pooled Analysis of Children's Oncology Group Trials

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Despite 5‐year survival rates of over 90% among children and adolescents/young adults (CAYAs) with classic Hodgkin lymphoma (cHL), 15%–20% relapse after frontline therapy. Prior analysis of frontline Children's Oncology Group (COG) clinical trials demonstrated that, despite similar rates of relapse, non‐Hispanic Black (NHB) and ...
Mallorie B. Heneghan, Lindsay A. Renfro, Yue Wu, Katia M. Crisler, Erin Marcotte, Tanya Trippett, Terzah Horton, Bradford S. Hoppe, Frank G. Keller, Chris Forlenza, Cindy Schwartz, Kara M. Kelly, Peter D. Cole, Sharon M. Castellino, Justine M. Kahn   +14 more
wiley   +1 more source